EWP
GILD icon

Elevation Wealth Partners’s Gilead Sciences GILD Stock Holding History

Elevation Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$183K Sell
1,226
-9
-0.7% -$1.26K 0.05% 151
2026
Q2 		$156K Buy
1,235
+107
+9% +$14.1K 0.05% 156
2026
Q1 		$157K Sell
1,128
-125
-10% -$17.5K 0.06% 132
2025
Q4 		$154K Buy
1,253
+145
+13% +$17.6K 0.05% 132
2025
Q3 		$123K Buy
1,108
+77
+7% +$8.75K 0.04% 156
2025
Q2 		$114K Hold
1,031
– – 0.05% 160
2025
Q1 		$101K Hold
1,031
– – 0.04% 170
2024
Q4 		$95.2K Hold
1,031
– – 0.04% 174
2024
Q3 		$86.4K Hold
1,031
– – 0.04% 178
2024
Q2 		$70.7K Hold
1,031
– – 0.03% 186
2024
Q1 		$81.1K Sell
1,031
-50
-5% -$3.85K 0.04% 179
2023
Q4 		$85.4K Hold
1,081
– – 0.05% 166
2023
Q3 		$81K Hold
1,081
– – 0.07% 113
2023
Q2 		$83.3K Sell
1,081
-116
-10% -$9.25K 0.07% 115
2023
Q1 		$99.3K Buy
+1,197
New +$99.1K 0.09% 103

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Elevation Wealth Partners's GILD Position: Q3 2026 in Review

Elevation Wealth Partners reduced its Gilead Sciences (GILD) stake by 0.73% in Q3 2026, selling an estimated $1.26K and leaving 1,226 shares worth $183K. The position accounts for 0.05% of the portfolio, ranked #151.

Elevation Wealth Partners first reported a position in GILD in Q1 2023 and has held it in 15 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Elevation Wealth Partners held 1,226 shares of Gilead Sciences worth $183K as of Q3 2026.
  • Elevation Wealth Partners sold 9 Gilead Sciences shares in Q3 2026, an estimated $1.26K.
  • Gilead Sciences made up 0.05% of Elevation Wealth Partners's portfolio in Q3 2026, its #151 holding.
  • Elevation Wealth Partners first reported a position in Gilead Sciences in Q1 2023 and has held it in 15 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.